Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
@article{TCR74332, author = {Daisuke Sano and Nobuhiko Oridate}, title = {Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial}, journal = {Translational Cancer Research}, volume = {12}, number = {5}, year = {2023}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/74332} }